This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Church & Dwight (CHD) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Coca-Cola (KO) Looks Poised for Q1 Earnings Beat
by Zacks Equity Research
Strength across the majority of the markets, investments in the marketplace and the cycling of last year's pandemic-led impacts are expected to have driven Coca-Cola's (KO) Q1 performance.
Kimberly-Clark (KMB) Queued for Q1 Earnings: Things to Note
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter 2022 performance is likely to reflect higher input cost inflation and supply-chain disruptions. Nevertheless, cost-saving efforts bode well.
Here's How Boston Beer (SAM) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
Slowdown in the hard seltzer business and supply-chain headwinds are likely to have marred Boston Beer's (SAM) Q1 volumes. Robust brand portfolio and strategic initiatives are expected to have aided.
What's in the Offing for Philip Morris (PM) in Q1 Earnings?
by Zacks Equity Research
Philip Morris' (PM) first-quarter 2022 results are likely to reflect certain hurdles related to the pandemic, such as soft duty-free sales in Asia. However, strong pricing has been an upside.
Church & Dwight (CHD) Up More Than 20% in 6 Months: Here's Why
by Zacks Equity Research
Church & Dwight (CHD) has been gaining on robust consumption and demand trends. The company's innovation and prudent acquisitions, together with pricing actions, have been aiding amid high costs.
Church & Dwight (CHD) Gains on Demand, Pricing Amid Cost Woes
by Zacks Equity Research
Church & Dwight (CHD) has been gaining on solid demand trends, with its brands getting a boost from innovation and buyouts. Also, the company's pricing has been aiding amid cost inflation.
Company News for Jan 31, 2022
by Zacks Equity Research
Companies In The News Are: V, CVX, WY, CHD.
Church & Dwight (CHD) Q4 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
Church & Dwight's (CHD) fourth-quarter 2021 performance reflects net sales and earnings growth on solid consumption for the company's brands.
Church & Dwight (CHD) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 10.34% and 1.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Things to Consider Before Church & Dwight's (CHD) Q4 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) fourth-quarter 2021 performance is likely to reflect gains from category growth and impressive brand performance. Also, prudent buyouts are upsides.
Church & Dwight (CHD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Church & Dwight (CHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 0.61% and 3.10%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
4 Soaps & Cleaning Materials Stocks to Watch Amid Cost Woes
by Rajani Lohia
Elevated logistics, input and manufacturing costs have been eroding margins for several soap and cleaning materials companies amid aggravated supply-chain woes. Players like Procter & Gamble (PG), Colgate (CL), Church & Dwight (CHD) and Clorox (CLX) are expected to benefit from innovation.
Church & Dwight (CHD) Inks Deal to Acquire TheraBreath Brand
by Zacks Equity Research
Church & Dwight (CHD) inks an agreement to acquire leading mouthwash brand, TheraBreath. The deal, valued at $580 million, is expected to close in fourth-quarter 2021.
Church & Dwight (CHD) Q3 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2021 results reflect solid product demand, though input cost inflation remains a deterrent.
Church & Dwight (CHD) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 12.68% and 2.23%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Church & Dwight (CHD) Lined Up for Q3 Earnings: Things to Note
by Zacks Equity Research
Solid demand as well as gains from prudent buyouts and product innovations are likely to aid Church & Dwight's (CHD) third-quarter 2021 results.
Church & Dwight (CHD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Church & Dwight (CHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Church & Dwight (CHD) Gains on High Demand Amid Cost Concerns
by Zacks Equity Research
Church & Dwight (CHD) has been benefiting from elevated demand amid the pandemic, including online. That said, elevated input costs and supply-chain headwinds weighed on its 2021 view.
Zacks Industry Outlook Highlights: Procter & Gamble, Unilever, Church & Dwight, Colgate-Palmolive and Clorox Co
by Zacks Equity Research
Zacks Industry Outlook Highlights: Procter & Gamble, Unilever, Church & Dwight, Colgate-Palmolive and Clorox Co
3 Soaps & Cleaning Materials Stocks to Wash Away Industry Blues
by Vidya Nair
Moderation in demand and rise in input costs are headwinds for several soap and cleaning materials companies. Nonetheless, efforts to boost offerings are aiding players like Procter & Gamble (PG), Unilever (UL) and Church & Dwight (CHD).
Church & Dwight (CHD) Cuts View Despite Q2 Earnings & Sales Beat
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results benefit from strong product demand. Management lowers view due to supply-chain woes and cost inflation.
Clorox (CLX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in fourth-quarter fiscal 2021. Nonetheless, its IGNITE strategy and cost-saving initiatives are encouraging.
Church & Dwight (CHD) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results are likely to reflect solid demand for household and personal care products, though escalated costs have been a concern.